{"disease":{"id":"renal-disease","name":"renal disease"},"drugs":{"marketed":[{"drug_id":"darbepoetin-alfa","indication_name":"Anemia of renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Aranesp","generic_name":"DARBEPOETIN ALFA","company_name":"Amgen","drug_phase":"marketed","molecular_target":"Erythropoietin receptor","drug_class":"Erythropoiesis-stimulating Agent [EPC]","quality_score":10,"revenue":"400","mechanism":"Aranesp works by binding to the erythropoietin receptor, mimicking the action of natural erythropoietin to stimulate red blood cell production."},{"drug_id":"ethacrynic-acid","indication_name":"Edema in Renal Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Edecrin","generic_name":"ETHACRYNIC ACID","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Glutathione S-transferase P","drug_class":"Loop Diuretic [EPC]","quality_score":45,"revenue":null,"mechanism":""},{"drug_id":"enarodustat","indication_name":"Anemia of renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Enaroy","generic_name":"ENARODUSTAT","company_name":"Japan Tabacco","drug_phase":"marketed","molecular_target":"Egl nine homolog 1","drug_class":"","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"daprodustat","indication_name":"Anemia of renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Jesduvroq","generic_name":"DAPRODUSTAT","company_name":"GSK","drug_phase":"marketed","molecular_target":"Egl nine homolog 1","drug_class":"Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Jesduvroq works by activating hypoxia-inducible factor prolyl hydroxylase inhibitors, which increases the production of erythropoietin, a hormone that stimulates red blood cell production."},{"drug_id":"irbesartan-hydrochloride","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avapro","generic_name":"IRBESARTAN HYDROCHLORIDE","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":10,"revenue":null,"mechanism":"Avapro works by blocking the action of angiotensin II, a hormone that constricts blood vessels and increases blood pressure."},{"drug_id":"losartan-potassium","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"LOSARTAN POTASSIUM","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker","quality_score":69,"revenue":null,"mechanism":"Cozaar works by blocking the action of angiotensin II on its receptor, which helps to relax blood vessels and lower blood pressure."},{"drug_id":"captopril","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Capozide 25/15","generic_name":"CAPTOPRIL","company_name":"Aarxion Anda Hlding","drug_phase":"marketed","molecular_target":"Renin","drug_class":"Thiazide Diuretic [EPC]","quality_score":57,"revenue":null,"mechanism":""},{"drug_id":"multihance-0-1-mmol-kg","indication_name":"Magnetic Resonance Angiography (MRA) to evaluate adults with known or suspected renal occlusive vascular disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MultiHance 0.1 mmol/kg","company_name":"Bracco Diagnostics, Inc","drug_phase":"marketed","molecular_target":"Water protons in tissue; blood-brain barrier; vascular endothelium","drug_class":"Paramagnetic contrast agent; gadolinium-based MRI contrast medium","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"torasemide","indication_name":"Renal Disease with Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Torasemide","company_name":"Medical University of Warsaw","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 1","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"aranesp","indication_name":"Anemia of renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Aranesp","company_name":"University of Washington","drug_phase":"marketed","molecular_target":"Erythropoietin receptor","drug_class":"","quality_score":16,"revenue":null,"mechanism":null},{"drug_id":"methylclothiazide","indication_name":"Renal Disease with Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Enduron","generic_name":"methylclothiazide","company_name":"","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 3","drug_class":"Thiazide Diuretic","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"losartan","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cozaar","generic_name":"losartan","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"AT1 receptor","drug_class":"ARB (Angiotensin II receptor blocker)","quality_score":65,"revenue":null,"mechanism":"Losartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 receptor."},{"drug_id":"calcitriol","indication_name":"Hypocalcemia from End-Stage Renal Disease with Dialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcijex","generic_name":"CALCITRIOL","company_name":"Esjay Pharma","drug_phase":"marketed","molecular_target":"Vitamin D3 receptor","drug_class":"Vitamin D3 Analog [EPC]","quality_score":60,"revenue":null,"mechanism":""},{"drug_id":"bumetanide","indication_name":"Renal Disease with Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bumex","generic_name":"BUMETANIDE","company_name":"","drug_phase":"marketed","molecular_target":"Solute carrier family 12 member 1","drug_class":"Loop Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"calcium","indication_name":"end stage renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcium Acetate","generic_name":"CALCIUM","company_name":"Fresenius Medcl Care","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":65,"revenue":null,"mechanism":"Calcium Acetate works by providing supplemental calcium to the body, which is essential for various bodily functions including muscle and nerve function."},{"drug_id":"calcium","indication_name":"end stage renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Calcium Acetate","generic_name":"CALCIUM","company_name":"Fresenius Medcl Care","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":65,"revenue":null,"mechanism":"Calcium Acetate works by providing supplemental calcium to the body, which is essential for various bodily functions including muscle and nerve function."},{"drug_id":"irbesartan","indication_name":"Diabetic renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Avapro","generic_name":"IRBESARTAN","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Type-1 angiotensin II receptor","drug_class":"Angiotensin 2 Receptor Blocker [EPC]","quality_score":65,"revenue":null,"mechanism":""},{"drug_id":"metolazone","indication_name":"Renal Disease with Edema","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zaroxolyn","generic_name":"METOLAZONE","company_name":"I3 Pharms","drug_phase":"marketed","molecular_target":"Carbonic anhydrase 7","drug_class":"Thiazide-like Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"torsemide","indication_name":"Edema associated with renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"TORSEMIDE","company_name":"","drug_phase":"marketed","molecular_target":"Na+/K+/2Cl- carrier system","drug_class":"Loop Diuretic [EPC]","quality_score":10,"revenue":null,"mechanism":"Torsemide inhibits the Na+/K+/2Cl- carrier system in the thick ascending limb of the loop of Henle, leading to increased excretion of sodium, chloride, and water."},{"drug_id":"darbepoetin","indication_name":"Anemia of renal disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Darbepoetin","company_name":"NICHD Neonatal Research Network","drug_phase":"marketed","molecular_target":"Erythropoietin receptor","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"sodium-succinate","indication_name":"Renal Diseases","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SODIUM SUCCINATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":""},{"drug_id":"rocaltrol","indication_name":"Hypocalcemia from End-Stage Renal Disease with Dialysis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Rocaltrol","company_name":"Shandong University","drug_phase":"marketed","molecular_target":"Vitamin D 25-hydroxylase, 25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial, Vitamin D-binding protein","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":22,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05220917","title":"Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":781430,"lead_sponsor_name":"Brigham and Women's Hospital","has_results":false},{"nct_id":"NCT03225586","title":"Prospective Urban Rural Epidemiology Study","phase":"","overall_status":"RECRUITING","enrollment_count":200000,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT05050877","title":"Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention II","phase":"","overall_status":"COMPLETED","enrollment_count":184855,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT06883318","title":"Physical, Psychological and Socioeconomic Effects of Childhood Onset Diabetes in Sweden","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":115000,"lead_sponsor_name":"Umeå University","has_results":false},{"nct_id":"NCT03575247","title":"The Risk of Adrenal Insufficiency and Cushing Syndrome Associated With Glucocorticoid Therapy in People With Chronic Inflammatory Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":111804,"lead_sponsor_name":"University of Leeds","has_results":false},{"nct_id":"NCT06614712","title":"OPTIMISE-CKD Study_current Clinical Landscape in Spain","phase":"","overall_status":"COMPLETED","enrollment_count":91628,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04407936","title":"Risk Factors and Prognosis of Adverse Cardiovascular and Kidney Events After Coronary Intervention","phase":"","overall_status":"COMPLETED","enrollment_count":88938,"lead_sponsor_name":"Guangdong Provincial People's Hospital","has_results":false},{"nct_id":"NCT03356340","title":"The Singapore Chinese Health Study","phase":"","overall_status":"UNKNOWN","enrollment_count":63257,"lead_sponsor_name":"Duke-NUS Graduate Medical School","has_results":false},{"nct_id":"NCT06521801","title":"Cardio-Renal Registry","phase":"","overall_status":"RECRUITING","enrollment_count":60000,"lead_sponsor_name":"Queen Mary University of London","has_results":false},{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT04531124","title":"Cardiovascular and Renal Outcomes of Integrated Management of Blood Pressure and Other Cardiometabolic Risks in Hypertensives","phase":"","overall_status":"UNKNOWN","enrollment_count":30000,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT01767883","title":"Improving Evidence-Based Primary Care for Chronic Kidney Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":27000,"lead_sponsor_name":"American Academy of Family Physicians","has_results":false},{"nct_id":"NCT05005572","title":"Treatment Choice and Outcomes for ESRD: Evidence From the First Year of a Nationwide Randomized Evaluation","phase":"NA","overall_status":"COMPLETED","enrollment_count":18621,"lead_sponsor_name":"Amy Finkelstein","has_results":false},{"nct_id":"NCT02769975","title":"Evaluation of Children With Endocrine and Metabolic-Related Conditions","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","has_results":false},{"nct_id":"NCT07033117","title":"RaDIANT Health Systems Intervention","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":14000,"lead_sponsor_name":"Indiana University","has_results":false},{"nct_id":"NCT04937868","title":"Developing a Decision Instrument to Guide Abdominal-pelvic CT Imaging of Blunt Trauma Patients","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06227468","title":"A Clinical Study to Map the HLA Genomic Region in the Greek Population","phase":"","overall_status":"RECRUITING","enrollment_count":12000,"lead_sponsor_name":"Athens LifeTech Park","has_results":false},{"nct_id":"NCT02933151","title":"Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)","phase":"NA","overall_status":"COMPLETED","enrollment_count":10457,"lead_sponsor_name":"Dialysis Clinic, Inc.","has_results":true},{"nct_id":"NCT05889806","title":"AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":10000,"lead_sponsor_name":"Audubon Bioscience","has_results":false},{"nct_id":"NCT03988491","title":"Morbidity, Mortality, Short and Long-term Survival of Hemodialysis End-stage Kidney Disease Patients in Central Tanzania","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Benjamin Mkapa Hospital","has_results":false},{"nct_id":"NCT03125265","title":"DIETary Intake, Death and Hospitalization in Adult With End-stage Kidney Disease Treated With HemoDialysis (DIET-HD) Study","phase":"","overall_status":"COMPLETED","enrollment_count":9757,"lead_sponsor_name":"Giovanni Strippoli","has_results":false},{"nct_id":"NCT05952999","title":"Analysis of the Virtual Acute Care at Home Experience","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":9654,"lead_sponsor_name":"OSF Healthcare System","has_results":false},{"nct_id":"NCT07312929","title":"Machine Learning and Artificial Intelligence Algorithms to Optimize the Performance and Delivery of Acute Dialysis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7500,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT02019225","title":"A Cluster-randomized, Pragmatic Trial of Hemodialysis Session Duration","phase":"NA","overall_status":"TERMINATED","enrollment_count":7053,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT05529186","title":"Causes of Mortality in Kidney Transplant Recipients","phase":"","overall_status":"UNKNOWN","enrollment_count":7000,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT05218304","title":"Baromètre Santé Adulte 2021-2022","phase":"NA","overall_status":"SUSPENDED","enrollment_count":5471,"lead_sponsor_name":"Agence Sanitaire et Sociale de Nouvelle Calédonie","has_results":false},{"nct_id":"NCT01467466","title":"Prevention of Serious Adverse Events Following Angiography","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5177,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT03899298","title":"Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"R3 Stem Cell","has_results":false},{"nct_id":"NCT04213664","title":"Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.","phase":"","overall_status":"UNKNOWN","enrollment_count":4666,"lead_sponsor_name":"Corporacion Parc Tauli","has_results":false},{"nct_id":"NCT03694431","title":"Comparative Trial of Home-Based Palliative Care","phase":"NA","overall_status":"TERMINATED","enrollment_count":3999,"lead_sponsor_name":"Kaiser Permanente","has_results":false},{"nct_id":"NCT00102544","title":"Use of Tracking Devices to Locate Abnormalities During Invasive Procedures","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":3894,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT03674307","title":"Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates","phase":"NA","overall_status":"RECRUITING","enrollment_count":3306,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT00559767","title":"Mapping of End Stage Renal Disease Genetic Susceptibility in African Americans by Admixture Linkage Disequilibrium","phase":"","overall_status":"COMPLETED","enrollment_count":2860,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05967806","title":"A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria","phase":"","overall_status":"COMPLETED","enrollment_count":2575,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07187596","title":"Mortality Outcome of Controlled Hypertension","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2547,"lead_sponsor_name":"DejthidaNathaphong","has_results":false},{"nct_id":"NCT05931276","title":"CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":2540,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT03020303","title":"Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2538,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT04088526","title":"Survey and Reduction of Mortality in Peridialysis Uremic Patients Via Intervention of Risk Factors","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT03978260","title":"Preoperative Anaemia prevaLence In surgiCal patiEnts","phase":"","overall_status":"COMPLETED","enrollment_count":2500,"lead_sponsor_name":"Johann Wolfgang Goethe University Hospital","has_results":false},{"nct_id":"NCT05225298","title":"SARS-COV-2 Screening in Dialysis Facilities","phase":"NA","overall_status":"COMPLETED","enrollment_count":2389,"lead_sponsor_name":"Stanford University","has_results":true},{"nct_id":"NCT06257134","title":"Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.","phase":"NA","overall_status":"RECRUITING","enrollment_count":2293,"lead_sponsor_name":"Central Hospital, Nancy, France","has_results":false},{"nct_id":"NCT01950819","title":"Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":2037,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06199609","title":"Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula","phase":"","overall_status":"COMPLETED","enrollment_count":2027,"lead_sponsor_name":"Haiyan Wang","has_results":false},{"nct_id":"NCT07524101","title":"Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":1952,"lead_sponsor_name":"Yonsei University","has_results":false},{"nct_id":"NCT07245186","title":"Strategies for Proactive Health in People With Kidney Function Decline","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1800,"lead_sponsor_name":"Huashan Hospital","has_results":false},{"nct_id":"NCT03815175","title":"XIENCE 28 USA Study","phase":"NA","overall_status":"COMPLETED","enrollment_count":1605,"lead_sponsor_name":"Abbott Medical Devices","has_results":true},{"nct_id":"NCT03171545","title":"Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1431,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT03227770","title":"The Benefit of Hemodialysis Plus Hemoperfusion on Mortality","phase":"NA","overall_status":"COMPLETED","enrollment_count":1362,"lead_sponsor_name":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}